金山雲(03896.HK)授出合共523.2萬個受限制股份單位
格隆匯3月20日丨金山雲(03896.HK)公告,公司於2025年3月20日根據2021年股權激勵計劃的條款向若幹僱員參與者授出合共523.2萬個受限制股份單位。
授出的目的旨在(i)通過將承授人的個人利益與股東的個人利益聯繫起來及通過就優異表現向有關人士提供獎勵以期爲股東帶來豐厚回報促進公司的成功及提升公司的價值;(ii)使公司能靈活激勵、吸引及挽留集團的董事及員工使之提供服務,而公司能否成功經營業務主要取決於該等人士的判斷、利益及特別努力。授出將激勵集團僱員進一步爲集團作出貢獻,並使彼等的利益與公司及股東的整體最佳利益一致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.